What’s New in December 2015
New performance data are available for the dashboards below.
Center for Biologics Evaluation and Research (CBER)
- CBER Dashboard: CBER successfully completed the International Key Project on the Scientific Collaboration and Management of the Cooperative Agreement with World Health Organization Year 3 in September 2015. Project accomplishments of Year 3 include continuation of a proof of concept study for an international hospital-based active surveillance system to investigate the association between measles-containing vaccines and two specific adverse events. These activities support the public health goal of enhancing access of the global population to safe and effective vaccines.
Center for Drug Evaluation and Research (CDER)
- CDER Dashboard: CDER’s Drug Supply Chain Security Act Key Project was the most viewed key project in FY15 Q4. This project promotes patient safety by enhancing the integrity and security of pharmaceutical supply chain through entities that handle and distribute human, finished, prescription drugs.
Center for Food Safety and Applied Nutrition (CFSAN)
- CFSAN Dashboard: In FY15, the Office of Cosmetics and Color completed 100% of its color additive regulatory package reviews received via FDA's electronic Compliance Management System (CMS) within its specified timeframe. Timely reviews help to speed enforcement actions related to potentially violative color additives in food and cosmetics.
Center for Tobacco Products (CTP)
- CTP Dashboard: CTP redesigned its dashboard to track performance measures that are aligned to their Strategic Areas that include: (1) Compliance and Enforcement; (2) Public Education; and (3) Science and Research.
Center for Veterinary Medicine (CVM)
- CVM Dashboard: In the last half of FY15, CVM was able to complete 100% of its warning letter reviews within 15 working days.
Office of the Commissioner (OC)
- OC Administrative Offices Dashboard: The FDA-wide Social Media Policy Key Project was completed and disseminated to FDA employees on November 9. It clearly defines processes and expectations for using social media on behalf of the Agency and for FDA employees’ personal capacity. The policy will help enhance FDA’s already robust social media program with solid strategy, adherence guidelines, and examples of the other policies that govern these practices.
January 2016 Upcoming Performance Data Updates
FDA-TRACK is an agency-wide performance management system that monitors FDA programs through key performance measures and projects. These measures and projects are updated quarterly.